A Phase 4, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With a History of Inadequate Response to Oral Preventive Medications
A Phase 4, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With a History of Inadequate Response to Oral Preventive Medications
This study is being conducted to evaluate the efficacy and tolerability of rimegepant for migraine prophylaxis in adults with a history of inadequate response to oral preventive medications
Inclusion Criteria:
Exclusion Criteria:
Stamford, Connecticut 06905, United States
Edgewater, Florida 32132, United States
Ormond Beach, Florida 32174, United States
North Massapequa, New York 11758, United States
Saint Nicolas Province de Liège, 4420, Belgium
Copenhagen NV, Capital Region 2400, Denmark
Frankfurt am Main, Hesse 60313, Germany
Ulm Baden-Wuerttemberg, 89073, Germany
Wroclaw, Lower Silesian Voivodeship 52-210, Poland
Edgebaston, Birmingham B16 8LT, United Kingdom
Great Yarmouth, Norfolk NR31 6LA, United Kingdom